Shanghai outpatient major-disease benefits: registration and payment

Start with the three Shanghai terms instead of a generic chronic-disease label

Use the participant's scheme and insured place to choose the correct track. Shanghai employee basic medical insurance uses outpatient major disease (门诊大病) for a defined local set of high-cost outpatient treatment categories. Shanghai resident basic medical insurance uses a resident serious-disease insurance layer after the basic resident transaction. Cross-province administration uses outpatient chronic and special disease or outpatient special disease for recognized categories that can be settled through the national network. A hospital employee may use an informal shorthand, but the registration receipt and settlement category should match the official route.

This terminology is a financial and administrative boundary, not a statement about clinical seriousness. A person can have a severe chronic condition without qualifying for Shanghai employee outpatient major-disease treatment, and a person insured outside Shanghai can arrive with a home-place outpatient chronic or special-disease recognition for a category that is not on Shanghai's local employee list. Keep four questions separate: what the responsible clinical team has diagnosed, whether the insured place lists the category, whether the participant has formal recognition or registration, and whether the chosen institution supports that category.

Do not generalize Shanghai's local rules outside Shanghai. Beijing, Guangzhou, Shenzhen and other pooling areas use different names, disease catalogues, provider selection and payment calculations. Even within Shanghai, the employee and resident routes are not interchangeable. If a settlement screen displays an unfamiliar code, ask the hospital medical-insurance office to state the Chinese benefit category, participant scheme, registered treatment item and current provider before paying.

• Employee local term: 门诊大病 — outpatient major disease
• Resident layer: 城乡居民大病保险 — resident serious-disease insurance
• Cross-province term: 门诊慢特病 or 门诊特病
• Diagnosis, recognition, provider use and payment remain separate
• Shanghai rules must not be generalized to another city

A diagnosis is clinical evidence. It is not automatic benefit recognition, provider registration or approval of every related outpatient expense.

Identify the employee or resident disease scope before collecting forms

For Shanghai employee insurance, the current municipal FAQ identifies severe uraemia dialysis, kidney-transplant anti-rejection treatment, malignant-tumour treatment and treatment for seven specified mental disorders. The malignant-tumour route includes chemotherapy, including specified endocrine treatment, radiotherapy, isotope treatment, interventional treatment, traditional Chinese medicine and necessary related examinations under the current cancer rule. The seven mental-disorder categories are schizophrenia, moderate or severe depression, mania, obsessive-compulsive disorder, intellectual disability with mental disorder, epilepsy with mental disorder and paranoid psychosis.

The resident serious-disease route includes severe uraemia dialysis, kidney-transplant anti-rejection treatment, malignant-tumour treatment and the specified mental-disorder treatment in qualifying institutions. It also includes haemophilia and aplastic anaemia for eligible Shanghai higher-education students, and haemophilia for eligible primary or secondary students and infants, as defined by the current measures. Qualifying out-of-Shanghai outpatient special-disease treatment can also enter the resident serious-disease structure under the applicable rules.

Do not infer eligibility from a translation, a laboratory result or a condition that appears on another city's list. Ask the qualified Shanghai institution which formal local treatment item it is assessing and which document supports that assessment. The responsible clinician decides diagnosis and treatment; the medical-insurance route decides whether that treatment item is within the local benefit catalogue. This guide cannot tell a patient to start, stop or substitute dialysis, cancer treatment, psychiatric treatment or medicine.

• Check the participant's exact scheme before using a disease list
• Ask for the formal Chinese treatment-item name
• Confirm that the institution holds the qualification for that item
• Do not import hypertension or diabetes from an incoming cross-province list
• Leave diagnosis and treatment decisions to the responsible clinical team

Verify active participation and identity before seeking recognition

Recognition cannot repair an inactive insurance record. Check the Shanghai insured place, employee or resident scheme, current benefit status, registered identity-document type and number, and the name linked to the medical-insurance credential. A social-security card, medical-insurance code, employer payslip or previous settlement is not sufficient proof that entitlement is active today. Benefit timing, contribution interruption, a resident waiting period or an employer change can affect the live record.

For a foreign participant, compare the current passport or Foreigner Permanent Residence Identity Card with the insurance record and hospital patient file. A renewed passport, different name order, omitted middle name or changed identity-document type can cause registration or settlement failure. Ask the responsible agency or hospital which record must be corrected; do not create a second patient identity, borrow another person's credential or assume the cashier can alter the insurance master record.

Legally employed foreign nationals have a route into employee social insurance through the employer or China-based work unit, and enrolled foreign employees receive the same applicable reimbursement treatment as local employees. Current resident rules also provide selected participation routes for qualifying foreign permanent residents, specified overseas-talent family members and certain students or children. These are eligibility pathways, not automatic enrolment. A tourist, short-term visitor, unregistered dependant or person with only private international insurance cannot use this public benefit.

Foreign nationality does not decide the result. Actual enrolment, active entitlement, identity matching and successful benefit registration do.

Obtain the hospital application and register the correct treatment item

Start at a medical institution qualified for the intended outpatient major-disease treatment item. The institution assesses the case under its clinical and insurance responsibilities and, when appropriate, issues the Shanghai outpatient major-disease application form. Take the current form, the participant's accepted identity document and medical-insurance credential to the qualified institution's registration route or a city, district, subdistrict or town medical-insurance service window identified by Shanghai. Obtain and retain the registration receipt.

For the same treatment item, Shanghai's current FAQ says only one qualified medical institution may be registered. This is narrower than choosing any hospital carrying a general medical-insurance designation. Match the exact legal institution and campus, ask whether it holds the relevant major-disease qualification, and confirm where treatment, tests and medicine pickup must occur. If a change is necessary, ask the current institution or medical-insurance office how to close or change the registration before using another provider.

The One-Stop service page still displays a six-month period and older policy references. Use it for the form, counter and receipt workflow, but use the controlling 2026 notice for validity. For a foreign passport or permanent-residence document, the service page does not clearly state what every online and counter channel accepts. Bring the registered identity document, medical-insurance credential and hospital form, and confirm the exact document route with the hospital or Shanghai medical insurance hotline 12393 before travel.

• Qualified institution's assessment and application form
• Registered identity document and medical-insurance credential
• Exact treatment item and institution
• Registration receipt and validity dates
• Assisted counter route if online identity verification fails

Use the one-year validity rule and keep it separate from clinical eligibility

From 1 April 2026, each Shanghai basic-medical-insurance major-disease registration is valid for one year. A registration still valid on 1 April received a six-month transition extension. The six-month statement still visible on some Shanghai service and older policy pages is not the current general registration period. Record the registration date, expiry date, treatment item, institution and receipt number; do not rely only on a reminder in a hospital app.

Administrative validity is not the same as continuing clinical eligibility. The malignant-tumour rule, for example, gives a general treatment-eligibility period of 24 months from initial diagnosis or recurrence and a five-year period for the specified traditional-Chinese-medicine route, with possible extension after medical-institution assessment. A person can therefore have a treatment-eligibility period extending beyond the current one-year registration and still need timely renewal of the registration. Conversely, an unexpired receipt does not override a change in the qualifying treatment item or clinical assessment.

Before expiry, ask the registered institution whether it must reassess the case, issue a new application or update the provider record. If treatment is continuing across an employer change, resident renewal, passport replacement or move, recheck active entitlement and identity as well. Renewal is an administrative continuation request, not a clinician instruction to continue treatment. The responsible medical team remains accountable for the clinical plan.

One year describes the registration record. It does not mean one year of guaranteed treatment, unlimited expenses or automatic renewal.

Calculate the employee route from eligible expense, not the headline invoice

For Shanghai employee outpatient major-disease treatment, current rules state that the basic fund pays 85 percent of expenses within the applicable payment scope for an active employee and 92 percent for a retiree. The phrase within the payment scope is essential. Catalogue status, medical-insurance limited-payment conditions, the registered treatment item, qualified provider, transaction category and any fully self-funded service are reviewed before the percentage can be meaningful. Do not multiply 85 or 92 percent by the hospital's total retail invoice.

For the 2026 employee medical-insurance year, from 1 July 2026 through 30 June 2027, the pooled fund annual maximum payment limit is RMB 670,000. This is an aggregate annual fund limit across covered employee-insurance categories, not a fresh RMB 670,000 allowance for each disease, hospital, prescription or registration. Shanghai states that the applicable expense above that annual limit continues to be paid at 80 percent. The hospital settlement statement and live annual accumulation, rather than a website calculator, determine the participant's position.

The current local sources reviewed for this guide do not state a separate outpatient major-disease deductible. Do not import the ordinary outpatient self-payment threshold or an inpatient deductible into this category without an official transaction basis. A patient can still owe the statutory personal percentage, noncovered items, amounts outside a limited-payment condition or services entered under another billing route. Ask for the medical-insurance settlement statement and an itemized list showing fund payment, personal payment and fully self-funded lines.

• 85 percent: active employee, within eligible payment scope
• 92 percent: retiree, within eligible payment scope
• RMB 670,000: 2026 insurance-year pooled-fund aggregate limit
• 80 percent: applicable above-limit portion
• No separate outpatient major-disease deductible stated in the reviewed current sources

Treat resident serious-disease insurance as a separate second-layer calculation

A Shanghai resident participant does not use the employee 85 or 92 percent formula. The resident basic-insurance transaction occurs first. Resident serious-disease insurance then pays 60 percent of the qualifying policy-scope personal burden. The 65 percent rate is limited to medical-assistance groups specifically enumerated in current Shanghai rules, such as defined extreme-poverty, minimum-living-security and related assistance categories. Do not translate this as a universal low-income uplift or apply it based on an informal description of household finances.

For 2026, the resident serious-disease insurance base annual maximum payment limit is RMB 400,000. Shanghai's current policy explanation also describes continuous-participation and zero-reimbursement incentives that can increase a personal limit, as well as interruption consequences that can reduce it. Therefore a website should call RMB 400,000 the base limit and direct the participant to the live record for the personal limit. It is not a separate RMB 400,000 amount for each disease.

Ask the hospital or agency to show the resident basic-insurance result, the remaining qualifying personal burden, the serious-disease payment and the participant's annual accumulation separately. A resident payment can fail because the basic record is inactive, the person is in a waiting period, the disease or participant category is not recognized, the provider route is wrong or an item is outside scope. Do not solve a resident failure by asking the cashier to apply the employee major-disease code.

Resident serious-disease insurance is not Shanghai employee outpatient major disease with a different percentage; it has a different scheme, sequence and annual-limit logic.

Confirm the exact qualified treatment institution and billing route

A general Shanghai medical-insurance designated-provider status is necessary for many transactions but is not proof that the institution holds every outpatient major-disease qualification. Ask the hospital medical-insurance office to confirm the legal entity, campus, treatment item and whether the intended department, day-treatment unit, hospital pharmacy or external-prescription route will use the registered category. For malignant tumours, the current rule says qualified institutions are principally level-two and level-three institutions, but it does not support publishing a guessed static hospital list.

At every visit, present the participant's own accepted credential and confirm that the encounter is linked to the current major-disease registration before paying for consultation, tests, treatment or medicine. A clinical appointment and a benefit registration are different records. An international, VIP or special-demand service inside a designated hospital can have a self-pay billing route; ask whether the particular service is entered through ordinary Shanghai basic insurance or a premium package.

Institution participation and technical capability can change. Verify close to the visit rather than relying on a screenshot from months earlier. If the registered provider cannot deliver a service, do not informally move the prescription or treatment to another institution and assume the same payment. Ask whether the registration must be changed, whether a compliant external prescription is available or whether the expense belongs in a different reimbursement route.

• Legal institution and exact campus
• Qualification for the registered treatment item
• Ordinary insured route versus international or premium service
• Hospital pharmacy, external prescription or treatment-unit coding
• Current registration link before payment

Use electronic external prescriptions and double-channel pharmacies conditionally

Shanghai implements the 2025 national medical-insurance drug catalogue from 1 January 2026. Payment requires more than a medicine name: the drug must remain in the current catalogue, the diagnosis and use must meet lawful clinical and medical-insurance limited-payment conditions, and the transaction must be connected to the appropriate insured treatment category. A drug prescribed during major-disease care can still be fully or partly self-funded when those requirements are not met.

When a Shanghai medical institution cannot stock an eligible outpatient or emergency medicine, the current route is an external prescription transmitted through the national medical-insurance electronic prescription centre. The participating pharmacy downloads and verifies the prescription and handles required traceability information. Shanghai does not accept a medical-insurance external prescription issued by an out-of-province hospital or a doctor not registered in Shanghai for this local pharmacy settlement route. A foreign prescription can inform a Shanghai clinician but does not authorize local medical-insurance dispensing.

For an eligible nationally negotiated medicine in the double-channel mechanism, a qualified pharmacy may apply the issuing institution's corresponding payment policy, including the registered outpatient major-disease category, only when all current conditions align. Check the exact drug, dosage form, limited-payment indication, electronic prescription, pharmacy qualification, stock and benefit coding. Do not publish a permanent pharmacy list or assume every retail branch in a chain qualifies. If the prescription downloads but payment fails, preserve the electronic prescription reference and ask which condition failed.

Prescription issued, medicine available and insurance payable are three separate states. Confirm all three before travelling to a pharmacy.

Complete both filing and special-disease registration for care outside Shanghai

A Shanghai participant planning qualifying outpatient chronic or special-disease treatment in another province must first complete cross-province medical-treatment filing through an official national or Shanghai route. Filing can reflect long-term residence or a temporary treatment situation, and the evidence can differ by filing type. The May 2026 Shanghai guide specifically flags an employer external-assignment certificate for an active employee in the relevant route. Use the current service checklist rather than assuming that an address alone is sufficient.

After filing, complete a separate cross-province outpatient chronic or special-disease registration. Select an institution in the filed area that has opened direct settlement for the relevant category, and upload the qualifying institution's disease certificate or benefit-recognition application as required. Shanghai's current outgoing guide lists five operational items: malignant-tumour radiotherapy, malignant-tumour chemotherapy, haemodialysis, peritoneal dialysis and kidney-transplant anti-rejection treatment. Ask the agency about another treatment item rather than forcing it into one of these codes.

At the registered network institution, present the social-security card or medical-insurance electronic credential and identify the special-disease transaction. If the system cannot settle directly, ask the provider for the exact failure message and retain the original receipt, itemized list, treatment record, prescription, registration proof and filing record. Shanghai employee and resident rules provide manual or miscellaneous reimbursement routes for qualifying situations, often with a six-month submission window, but paying first does not guarantee reimbursement. Obtain a case-specific current checklist.

• Cross-province filing first
• Separate outpatient chronic or special-disease registration second
• Network provider that supports the precise category
• Disease evidence from a qualified institution
• Direct settlement credential and manual-reimbursement fallback file

Keep incoming cross-province categories separate from Shanghai's local list

Shanghai, as a place of treatment, supports national direct settlement for ten outpatient chronic and special-disease categories: hypertension, diabetes, malignant-tumour outpatient radiotherapy or chemotherapy, uraemia dialysis, organ-transplant anti-rejection treatment, chronic obstructive pulmonary disease, rheumatoid arthritis, coronary heart disease, viral hepatitis and ankylosing spondylitis. This network capacity serves eligible patients insured elsewhere; it does not convert all ten into Shanghai employee outpatient major diseases.

An incoming patient must obtain recognition and filing under the home insured place's rules, then select a Shanghai network institution that supports the exact category. The common direct-settlement allocation is treatment-place catalogue and insured-place benefit: Shanghai's medicine, medical-service and consumables scope applies as the place of care, while the home insured place controls disease recognition, deductible, payment percentage and maximum limit. A Shanghai cashier cannot replace missing home-place recognition.

Provider counts and supported categories are dynamic. Use the National Healthcare Security Administration service platform to check the exact Shanghai institution and category near the appointment, then confirm the campus with the provider. If the category is recognized at home but unavailable for direct settlement at the chosen provider, ask the home agency about another network institution or its manual reimbursement route. Do not assume every locally recognized disease or every Shanghai designated hospital participates in national special-disease settlement.

Shanghai's ten incoming cross-province categories describe network service capacity, not Shanghai's local employee outpatient major-disease catalogue.

Preserve evidence and classify a failed direct settlement before paying

A failed scan can represent inactive participation, an identity mismatch, expired registration, the wrong institution, missing category support, a service coded outside the registration, catalogue exclusion or a temporary system problem. Ask the hospital or pharmacy to state the exact transaction status and whether it can correct and retry before the account closes. Do not cycle through different identities, cards or self-pay profiles in the hope that one works.

If full payment is necessary, collect the original or authoritative electronic medical-fee receipt, itemized charge list, medical-insurance settlement or failure record, outpatient record, prescription, treatment certificate, registration receipt, provider details and any cross-province filing proof. For a medicine transaction, also retain the electronic prescription reference and pharmacy information. A payment screenshot alone does not show what was purchased or why direct settlement failed.

Contact Shanghai 12393 or the responsible district service with a narrow question: which scheme and treatment item were registered, whether the registration was valid on the expense date, which provider and transaction category were used, why direct settlement failed, and whether the facts fit an eligible manual reimbursement route. Record the enquiry date and reference. Manual reimbursement is a review process, not a promise that every self-paid cost will be returned.

• Exact error message and transaction category
• Active-entitlement and identity evidence
• Registration receipt and validity dates
• Original receipt, itemization and treatment records
• Electronic prescription or cross-province filing proof where relevant
• Official enquiry and submission reference

Build a foreign-participant file without assuming passport access

For an enrolled foreign employee, assemble the registered passport or identity-document details, Shanghai insurance number, employer and scheme, current entitlement query, medical-insurance credential, hospital patient number, major-disease application and registration receipt. If the passport has changed, confirm whether the insurance record, social-security card and hospital file have all been updated. A work permit or residence permit can support another administrative process but does not replace the insurance status check.

For a person seeking the resident route, first identify the exact current participation category. A Foreigner Permanent Residence Identity Card, overseas-talent family relationship or student status can create a possible route only when the current Shanghai rule covers the person and enrolment has actually been completed. Keep the enrolment result and benefit start date. Do not promise resident serious-disease payment to a nonworking spouse or child merely because another family member is insured.

Shanghai's official English guidance states that overseas medical expenses are not reimbursed through Shanghai basic medical insurance. It also supports equal applicable reimbursement treatment for an enrolled foreign employee, not preferential access to an international department. Public insurance, a hospital's international-service package and private insurer direct billing are separate interfaces. Confirm each one independently and maintain a self-pay reserve for patient shares, excluded items and premium services.

If an urgent medical problem arises, seek appropriate emergency care and call 120 when needed. Do not delay care while resolving registration or reimbursement questions.